| | Chemical Susceptibility, Injury and Reactivity: Mechanisms and |
| | 0,33 | | MB | Measurement with emphasis on developmental and receptor- |
| | 92 | | stron | ligand considerations |
| | 2972 | | ID | S.C. Rowat |
| | 2001 | | rok |
| | Brief Table of Contents |
| | Full Table of Contents .iv |
| | Abstract.. vi |
| | Abbreviations Usedvii |
| | 1. Introduction and Overview of CSIR 1 |
| | 1A. Context and Aims .1 |
| | 1B. Overview Hypothesis: Susceptibility, Injury, and Reactivity .1 |
| | 1C. Formulating CSIR Mechanism Models .2 |
| | 2. Specific CSIR Mechanisms: Newer Candidates ..4 |
| | 2A. Genetic Variation in Xenobiotic Metabolizing Enzymes (XMEs) ..4 |
| | 2B. Modulation of Receptor-Ligand Systems .5 |
| | 2C. Early Developmental Windows .11 |
| | 2D. Chronic Modulators as CSIR Mechanisms..22 |
| | 2E. Combined and Synergistic Mechanisms 35 |
| | 3. CSIR Measurement: what, how, and examples 37 |
| | 3A. Symptoms: Static, Cyclic, and Triggered .37 |
| | 3B. Instruments: Machine, Patient, and Clinician .37 |
| | 3C. Complexity of Individual CSIR Study Designs .39 |
| | 3D. CSIR Measurement Discussion and Postulates .44 |
| | 4. Final Discussion: Theories and Implications..48 |
| | 4A. Function Switching Further Explored 48 |
| | 4B. Is the Receptor-ligand Web a Form of Factor Analysis?..49 |
| | 4C. Chemical Reactivity as Complex Phenomena 51 |
| | 4D. Implications For Chemical Study and Control ..53 |
| | 5. Summary .57 |
| | 6. Final Conclusions.60 |
| | 7. Appendix: OP Study Summaries ..61 |
| | 7A. OP Animal Studies61 |
| | 7B. Human OP Studies 62 |
| | 8. References65 |